{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:31:49Z","timestamp":1759422709136,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40264-015-0382-9","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T12:55:56Z","timestamp":1453380956000},"page":"261-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1094-6364","authenticated-orcid":false,"given":"Christian","family":"Hampp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9360-1379","authenticated-orcid":false,"given":"Simone P.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"issue":"20","key":"382_CR1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMp1006189","volume":"363","author":"NK Choudhry","year":"2010","unstructured":"Choudhry NK, Shrank WH. Four-dollar generics\u2013increased accessibility, impaired quality assurance. N Engl J Med. 2010;363(20):1885\u20137.","journal-title":"N Engl J Med."},{"issue":"5","key":"382_CR2","doi-asserted-by":"crossref","first-page":"e1000074","DOI":"10.1371\/journal.pmed.1000074","volume":"6","author":"S Chimonas","year":"2009","unstructured":"Chimonas S, Kassirer JP. No more free drug samples? PLoS Med. 2009;6(5):e1000074.","journal-title":"PLoS Med."},{"issue":"8","key":"382_CR3","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2105\/AJPH.2008.138800","volume":"98","author":"WR Vincent","year":"2008","unstructured":"Vincent WR, Wiesner AM, Steinke DT. \u201cFree\u201d prescription drug samples are not free. Am J Public Health. 2008;98(8):1348\u20139.","journal-title":"Am J Public Health."},{"issue":"4","key":"382_CR4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MLR.0b013e3181618ee0","volume":"46","author":"GC Alexander","year":"2008","unstructured":"Alexander GC, Zhang J, Basu A. Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care. 2008;46(4):394\u2013402.","journal-title":"Med Care."},{"issue":"7","key":"382_CR5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1525-1497.2000.08014.x","volume":"15","author":"LD Chew","year":"2000","unstructured":"Chew LD, O\u2019Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS. A physician survey of the effect of drug sample availability on physicians\u2019 behavior. J Gen Intern Med. 2000;15(7):478\u201383.","journal-title":"J Gen Intern Med."},{"issue":"5","key":"382_CR6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1370\/afm.1135","volume":"8","author":"DM Hartung","year":"2010","unstructured":"Hartung DM, Evans D, Haxby DG, Kraemer DF, Andeen G, Fagnan LJ. Effect of drug sample removal on prescribing in a family practice clinic. Ann Fam Med. 2010;8(5):402\u20139.","journal-title":"Ann Fam Med."},{"issue":"9","key":"382_CR7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/SMJ.0b013e3181814d52","volume":"101","author":"DP Miller","year":"2008","unstructured":"Miller DP, Mansfield RJ, Woods JB, Wofford JL, Moran WP. The impact of drug samples on prescribing to the uninsured. South Med J. 2008;101(9):888\u201393.","journal-title":"South Med J."},{"issue":"2","key":"382_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.1997.03550020073041","volume":"278","author":"JM Westfall","year":"1997","unstructured":"Westfall JM, McCabe J, Nicholas RA. Personal use of drug samples by physicians and office staff. JAMA. 1997;278(2):141\u20133.","journal-title":"JAMA."},{"issue":"3","key":"382_CR9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1331\/JAPhA.2007.06046","volume":"47","author":"MN Mabins","year":"2003","unstructured":"Mabins MN, Emptage RE, Giannamore MR, Hall LE. Drug sample provision and its effect on continuous drug therapy in an indigent care setting. J Am Pharm Assoc. 2003;47(3):366\u201372.","journal-title":"J Am Pharm Assoc."},{"issue":"5","key":"382_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jamadermatol.2013.9715","volume":"150","author":"MP Hurley","year":"2014","unstructured":"Hurley MP, Stafford RS, Lane AT. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea. JAMA Dermatol. 2014;150(5):487\u201393.","journal-title":"JAMA Dermatol."},{"issue":"2","key":"382_CR11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2105\/AJPH.2007.114249","volume":"98","author":"SL Cutrona","year":"2008","unstructured":"Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU. Characteristics of recipients of free prescription drug samples: a nationally representative analysis. Am J Public Health. 2008;98(2):284\u20139.","journal-title":"Am J Public Health."},{"issue":"6","key":"382_CR12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11606-008-0568-2","volume":"23","author":"J Tjia","year":"2008","unstructured":"Tjia J, Briesacher BA, Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, et al. Medicare beneficiaries and free prescription drug samples: a national survey. J Gen Intern Med. 2008;23(6):709\u201314.","journal-title":"J Gen Intern Med."},{"issue":"1","key":"382_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40471-014-0027-z","volume":"2014","author":"M Johnsson Funk","year":"2014","unstructured":"Johnsson Funk M, Landi NL. Misclassification in administrative claims data: quantifying the impact of treatment effect estimates. Curr Epidemiol Rep. 2014;2014(1):175\u201385.","journal-title":"Curr Epidemiol Rep."},{"issue":"10","key":"382_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/pds.981","volume":"13","author":"S Jacobus","year":"2004","unstructured":"Jacobus S, Schneeweiss S, Chan KA. Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors. Pharmacoepidemiol Drug Saf. 2004;13(10):695\u2013702.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"12","key":"382_CR15","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s11606-011-1801-y","volume":"26","author":"WF Gellad","year":"2011","unstructured":"Gellad WF, Huskamp HA, Li A, Zhang Y, Safran DG, Donohue JM. Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication. J Gen Intern Med. 2011;26(12):1458\u201364.","journal-title":"J Gen Intern Med."},{"issue":"8","key":"382_CR16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/pds.3458","volume":"22","author":"JC Lauffenburger","year":"2013","unstructured":"Lauffenburger JC, Balasubramanian A, Farley JF, Critchlow CW, O\u2019Malley CD, Roth MT, et al. Completeness of prescription information in US commercial claims databases. Pharmacoepidemiol Drug Saf. 2013;22(8):899\u2013906.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"9","key":"382_CR17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/MLR.0000000000000174","volume":"52","author":"X Li","year":"2014","unstructured":"Li X, Sturmer T, Brookhart MA. Evidence of sample use among new users of statins: implications for pharmacoepidemiology. Med Care. 2014;52(9):773\u201380.","journal-title":"Med Care."},{"key":"382_CR18","unstructured":"Vigamox label. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021598s017lbl.pdf . [Accessed 21 Nov 2014]."},{"key":"382_CR19","unstructured":"Avelox label. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021085s057,021277s054lbl.pdf . [Accessed 20 Nov 2014]."},{"issue":"12","key":"382_CR20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0895-4356(89)90116-9","volume":"42","author":"HA Guess","year":"1989","unstructured":"Guess HA. Behavior of the exposure odds ratio in a case-control study when the hazard function is not constant over time. J Clin Epidemiol. 1989;42(12):1179\u201384.","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"382_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jval.2011.08.005","volume":"15","author":"JM Gamble","year":"2012","unstructured":"Gamble JM, McAlister FA, Johnson JA, Eurich DT. Quantifying the impact of drug exposure misclassification due to restrictive drug coverage in administrative databases: a simulation cohort study. Value Health. 2012;15(1):191\u20137.","journal-title":"Value Health."},{"key":"382_CR22","unstructured":"Zocor label. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/019766s091lbl.pdf . [Accessed 20 Nov 2014]."},{"key":"382_CR23","unstructured":"Yaz label. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/021676s012lbl.pdf . [Accessed 20 Nov 2014]."},{"issue":"9","key":"382_CR24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915\u201320.","journal-title":"Am J Epidemiol."},{"issue":"7","key":"382_CR25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0895-4356(94)90170-8","volume":"47","author":"Y Moride","year":"1994","unstructured":"Moride Y, Abenhaim L. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol. 1994;47(7):731\u20137.","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"382_CR26","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/dc10-1068","volume":"34","author":"JD Lewis","year":"2011","unstructured":"Lewis JD, Ferrara A, Peng T, Hedderson M, Bilker WB, Quesenberry CP Jr, et al. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care. 2011;34(4):916\u201322.","journal-title":"Diabetes Care."},{"key":"382_CR27","unstructured":"Food and Drug Administration. Drug safety communication: ongoing safety review of actos (pioglitazone) and potential increased risk of bladder cancer after two years exposure. September 17, 2010. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm226214.htm . [Accessed 21 Nov 2014]."},{"issue":"5","key":"382_CR28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2337\/dc13-2289","volume":"37","author":"C Hampp","year":"2014","unstructured":"Hampp C, Borders-Hemphill V, Moeny DG, Wysowski DK. Use of antidiabetic drugs in the US, 2003\u20132012. Diabetes Care. 2014;37(5):1367\u201374.","journal-title":"Diabetes Care."},{"issue":"4","key":"382_CR29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1542\/peds.2007-2928","volume":"122","author":"SL Cutrona","year":"2008","unstructured":"Cutrona SL, Woolhandler S, Lasser KE, Bor DH, Himmelstein DU, Shrank WH, et al. Free drug samples in the United States: characteristics of pediatric recipients and safety concerns. Pediatrics. 2008;122(4):736\u201342.","journal-title":"Pediatrics."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-015-0382-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-015-0382-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:41:38Z","timestamp":1559490098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-015-0382-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1007\/s40264-015-0382-9","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"type":"print","value":"0114-5916"},{"type":"electronic","value":"1179-1942"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}